News for TFF Pharmaceuticals, Inc. (TFFP)

PR NewswireFOXBOROUGH, Mass., Feb. 6, 2025 FOXBOROUGH, Mass., Feb. 6, 2025 /PRNewswire/ -- TFF Pharmaceuticals, Inc. (Nasdaq: TFFP) today announced that th

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.53%

U.S. stocks traded mostly lower this morning, with the Nasdaq Composite falling more than 50 points on Thursday. Following the market opening Thursday, the Dow...

Shares of DBV Technologies S.A. DBVT rose sharply in the pre-market trading after the company announced alignment with the FDA on an accelerated approval pathwa...

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 300 points on Wednesday. The Dow traded up 0.49% to 44,296.79 whi...

U.S. stocks traded mostly higher this morning, with the Nasdaq Composite gaining more than 1% on Wednesday. Following the market opening Wednesday, the Dow tra...

On November 15, 2024, Carlson Capital, L.P. (Trades, Portfolio) executed a notable transaction involving TFF Pharmaceuticals Inc. The firm significantly reduced

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.70%

U.S. stocks traded lower toward the end of trading, with the Dow Jones index falling by more than 300 points on Friday. The Dow traded down 0.78% to 43,410.32 ...

U.S. stocks traded lower midway through trading, with the S&P 500 falling by over 1% on Friday. The Dow traded down 0.90% to 43,356.00 while the NASDAQ fell 2....

U.S. stocks traded lower this morning, with the Nasdaq Composite falling by more than 200 points on Friday. Following the market opening Friday, the Dow traded...

FORT WORTH, Texas, Nov. 30, 2023 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on...

NEW YORK, Nov. 10, 2023 (GLOBE NEWSWIRE) -- The Benchmark Company is pleased to announce its 12th Annual Discovery One-on-One Investor Conference to be...

/PRNewswire/ -- The latest market analysis report titled Immunosuppressants Market by Drug Class and Geography - Forecast and Analysis 2022-2026 has been added...

Read Investment Analysts’ Downgrades for June 8th (APTV, ATTRF, BNS, BROS, CGC, CNQ, CZOO, DEO, FLNG, GTLS) at ETF Daily News

Read Analysts’ Upgrades for June 1st (BME, BMRRY, BPMC, DHR, DLTR, DMRC, FINV, FMX, GCHEF, HBCP) at ETF Daily News

Read Stock Analysts’ Upgrades for May 26th (ABC, ALHC, CI, CNI, CNR, CPBLF, DKS, DQ, ELRXF, ELUXY) at ETF Daily News

/PRNewswire/ -- NRx Pharmaceuticals (NRx) (Nasdaq: NRXP), a clinical stage biopharmaceutical company today provided a business update and financial results for...

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Au...